Zimmer Biomet Reports Q1 2026 Earnings with Strong Sales and Earnings Growth
Zimmer Biomet (ZBH) reported Q1 2026 earnings with net sales of $2.087 billion, up 9.3% reported and 2.9% on an organic constant currency basis. Adjusted EPS rose 15% year-over-year to $2.09, driven by tariff-related benefits and improved gross margin. The company also repurchased $250 million in shares during the quarter.
Topics: Earnings Gross Margin Operating Margin Profitability Revenue Growth Stock Repurchases